Hepatitis B virus infection among street youths in Montreal

CMAJ. Canadian Medical Association Journal

Volumn 161, Issue 6, 1999, Pages 689-693

  Roy, Élise ^a   Haley, Nancy ^a   Lemire, Nicole ^a   Boivin, Jean François ^b   Leclerc, Pascale ^a   Vincelette, Jean ^c  

^a Gouvernement du Quebec   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANADA; FEMALE; HEPATITIS B; HIGH RISK POPULATION; HOMELESSNESS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROSTITUTION; RISK;

EID: 0033592411     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hepatitis B in Canada: surveillance summary 1980-1989. Can Dis Wkly Rep 1991;17(31):166-71.
2. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999;17(13-14):1730-3.
3. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1-24.
4. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92.
5. Duval B, Boulianne N, De Serres G, De Wals P, Masse R, Trudeau G, et al. Should children with isolated anti-HBs or anti-HBc be immunized against hepatitis B virus? [letter]. JAMA 1997;278(13):1064.
6. Glasgow KW, Schabas R, Williams D, Wallace F, Nalezyty LA. A population-based hepatitis B scroprevalence and risk factor study in a Northern Ontario town. Can J Public Health 1997;88(2):87-90.
7. Morris BAP, Harason P, Butler-James D. Seroprevalence of hepatitis B in a small urban sexually transmitted disease clinic. Can J Public Health 1992;83:733-74.
8. Torres RA, Mani S, Altholz J, Bricker PW. Human immunodeficiency virus infection among homeless men in a New York City shelter. Arch Intern Med 1990;150:2030-6.
9. Wang E, King S, Goldberg E, Bock B, Milner R, Read S. Hepatitis B and human immunodeficiency virus infection in Street youth in Toronto, Canada. Pediatr Infect Dis J 1991;10:130-3.
10. Alderman EM, Shapiro A, Spigland I, Coupey SM, Bashir M, Fox AS. Are there risk factors for hepatitis B infection in inner-city adolescents that justify prevaccination screening? J Adolesc Health 1998;22:389-93.
11. Roy E, Haley N, Boivin JF, Vincelette J, Lemire N. HIV infection among street youth: prevalence study. Montreal: Direction de la santé publique, Régie régionale de la santé et des services sociaux Montréal-Centre; 1996.
12. Roy E, Haley N, Boivin JF, Claessens C, Frappier JY, Lemire N. Injection drug use among street youth: a dynamic process. Can J Infect Dis 1997;8:29A.
13. Réflexion sur la situation des jeunes sans abri Montreal. Rapport du Comité de travail à Pattention du Comité de suivi du Programme conjoint Ville de Montréal-Ministère de la Santé et des Services sociaux; 1993.
14. Neaigus A, Friedman SR, Jose B, Goldstein MF, Curtis R, Ildefonso G, et al. High-risk personal network and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retroviral 1996;11:499-509.
15. Read S, De Matteo D, Bock B, Coats R, Golderg E, King S, et al. HIV prevalence in Toronto street youths. Toronto: Hospital for Sick Children; 1993. p. 18.
16. Smart RG, Adlaf EM, Walsh GW, Zdanowick YM. Drifting and doing: changes in drug use among Toronto street youth, 1990-92. Toronto: Addiction Research Foundation; 1992. p. 48.